Novo Nordisk A/S (NVO)
43.24
+0.05
(+0.12%)
USD |
NYSE |
Sep 18, 16:00
43.26
+0.02
(+0.05%)
After-Hours: 20:00
Novo Nordisk Free Cash Flow : 7.517B for June 30, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2026 | 7.517B |
| March 31, 2026 | 1.913B |
| December 31, 2025 | 4.400B |
| September 30, 2025 | 9.280B |
| June 30, 2025 | 9.063B |
| March 31, 2025 | 13.70B |
| December 31, 2024 | 10.21B |
| September 30, 2024 | 9.776B |
| June 30, 2024 | 9.572B |
| March 31, 2024 | 7.325B |
| December 31, 2023 | 10.16B |
| September 30, 2023 | 11.14B |
| June 30, 2023 | 9.475B |
| March 31, 2023 | 9.378B |
| December 31, 2022 | 9.060B |
| September 30, 2022 | 8.117B |
| June 30, 2022 | 8.541B |
| March 31, 2022 | 9.275B |
| December 31, 2021 | 7.568B |
| September 30, 2021 | 6.688B |
| June 30, 2021 | 5.337B |
| March 31, 2021 | 4.928B |
| December 31, 2020 | 4.571B |
| September 30, 2020 | 6.716B |
| June 30, 2020 | 7.042B |
| Date | Value |
|---|---|
| March 31, 2020 | 5.512B |
| December 31, 2019 | 5.332B |
| September 30, 2019 | 5.521B |
| June 30, 2019 | 4.734B |
| March 31, 2019 | 5.012B |
| December 31, 2018 | 5.101B |
| September 30, 2018 | 5.118B |
| June 30, 2018 | 5.454B |
| March 31, 2018 | 4.578B |
| December 31, 2017 | 4.935B |
| September 30, 2017 | 5.645B |
| June 30, 2017 | 5.834B |
| March 31, 2017 | 6.505B |
| December 31, 2016 | 5.954B |
| September 30, 2016 | 5.858B |
| June 30, 2016 | 5.639B |
| March 31, 2016 | 5.333B |
| December 31, 2015 | 4.892B |
| September 30, 2015 | 4.706B |
| June 30, 2015 | 5.053B |
| March 31, 2015 | 4.767B |
| December 31, 2014 | 4.868B |
| September 30, 2014 | 4.762B |
| June 30, 2014 | 3.687B |
| March 31, 2014 | 3.477B |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| AstraZeneca PLC | 8.051B |
| GSK Plc | 6.621B |
| Johnson & Johnson | 22.61B |
| Eli Lilly & Co. | 13.56B |
| Merck & Co., Inc. | 16.06B |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 8.364B |
| Cash from Investing (Quarterly) | -2.009B |
| Cash from Financing (Quarterly) | -2.708B |
| Free Cash Flow Per Share (Quarterly) | 1.434 |
| Free Cash Flow to Equity (Quarterly) | 7.500B |
| Free Cash Flow to Firm (Quarterly) | 6.544B |
| Free Cash Flow Yield | 3.91% |